Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Abatacept in Japanese RA Patients
NCT00484289Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2006
- Primary completion
- Dec 2010
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Dec 2006; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00484289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484289.